Harris et al. ‘Enzyme Purification Using Temperature Induced Phase Formation’, Bioseparation vol. 2, pp. 237-246, 1991.* |
Calabresi et al. ‘Molecular Characterization Of Native And Recombinant Apolipoprotein A-I Milano Dimer’, J. of Biol. Chem. vol. 269, No. 23, pp. 32168-32174, Dec. 23, 1994.* |
Database Caplus on STN. No. 1995:421793. Soma et al. ‘Recombinant Apolipoprotein A-Imilano Dimer Inhibits Carotid Intimal Thickening Induced By Pervascular Manipulation In Rabbits’, Circ. Res. vol. 76, No. 3, pp. 405-411, 1995.* |
Anspach, et al., “Removal of endotoxins by affinity sorbents,” J Chromatogr A 711(1):81-92 (1995). |
Badimon, et al., “Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit,” J. Clin Invest 85(4):1234-41 (1990). |
Cohn, et al., “Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids,” J. Am. Chem. Soc. 68: 459-475 (1946). |
Dorland's Illustrated Medical Dictionary (Twenty-fifth Edition) W.B. Saunders Publishers, 1974. |
Emancipator, et al., “In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins,” Infect Immun 60(2):596-601 (1992). |
Fransechini, et al, “Apolipoprotein AIMilano. Accelerated binding and dissociation from lipids of a human apolipoprotein variant,” J Biol Chem 260(30):16321-5 (1985). |
Fransechini, et al. “Apolipoprotein AIMilano. Disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma,” J Biol Chem 265(21):1224-31 (1990). |
Fransechini, et al. “High density lipoprotein-3 heterogeneity in subjects with the apo-AIMilano variant,” J. Biol. Chem. 257(17): 9926-30 (1982). |
Freudenberg, et al., “Natural Toxins,” Proc. Inc. Symp. Anim., Plant Microb. Toxins, 6th ed. pp. 349-354. |
Index, 11eEd., Merck and Co., Rahway, NJ, pp. 342 and 455 (1989). |
Isaachi, et al., “Mature apolipoprotein AI and its precursor proApoAI: influence of the sequence at the 5′ end of the gene on the efficiency of expression in Escherichia coli,” Gene 81(1):129-37 (1989). |
Karplus, et al., “A new method for reduction of endotoxin contamination from protein solutions,” J Immunol Methods 105(2):211-20 (1987). |
Lerch, et al., “Isolation and Properties of Apolipoprotein A for Therapeutic Use,” Protides Biol. Fluids 36: 409-416 (1989). |
Matsumae, et al., “Specific removal of endotoxin from protein solutions by imobilized histidine,” Biotechnol Appl Biochem 12(2):129-40 (1990). |
Medzour, et al. “Anion-exchange fast protein liquid chromatographic characterization and purification of apolipoproteins A-I, A-II, C-I, C-II, C-III0, C-III1, C-III2 and E from human plasma,” J Chromatogr. 414(1):35-45 (1987). |
Minobe, et al., “Characteristics and applications of adsorbents for pyrogen removal,” Biotechnol Appl Biochem 10(2):143-53 (1988). |
Moguilevsky, et al., “Production of human recombinant proapolipoprotein A-I in Escherichia coli: purification and biochemical characterization,” DNA 8(6):429-36 (1989). |
Munford, et al., “Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins,” Infect Immun 34(3):835-43 (1981). |
Nilsson, et al., “Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors,” EMBO J. 4(4):1075-80 (1985). |
Nitschmann, et al., “Vereinfachtes Verfahen zur Gewinnung von humanem Albumin und—Globulin aus Blutplasma mittels Alkoholfallung,” Helv. Chim. Acta. 37:866-873 (1954). |
O'Brien, et al., “Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins,” Circulation 98(6):519-27 (1998). |
Oncley, et al., “The separation of the Antibodies, Isogglutinins, Prothrombin, Plasminogen and β1—Lipoprotein into Subfractions of Human Plasma,” J. Am. Chem. Soc. 71: 541-550 (1949). |
Peitsch, et al., “A purification method for apolipoprotein A-I and A-II,” Anal Biochem. 178(2):301-5 (1989). |
Pigiet, et al., “Thioredoxin-catalyzed refolding of disulfide-containing proteins,” Proc Natl Acad Sci U S A. 83(20):7643-7 (1986). |
Ross, et al., “Rapid chromatographic purification of apolipoproteins A-I and A-II from human plasma,” Anal Biochem 149(1):166-8 (1985). |
Rubenstein, et al., “A new method for the fractionation of human plasma high density lipoprotein,” Can J Biochem. 55(7):766-8 (1977). |
Segrest, et al., “A molecular theory of lipid-protein interactions in the plasma lipoproteins,” FEBS Lett. 38(3):247-58 (1974). |
Sharma, et al., “Endotoxin detection and elimination in biotechnology,” Biotechnol Appl Biochem. 8(1):5-22 (1986). |
Ulevitch, et al., “New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma,” J Clin Invest 67(3):827-37 (1981). |
Walter, et al. Partitioning procedures and techniques: cells, organelles, and membranes, Methods Enzymol 228:42-63 (1994). |
Weisgraber, et al. “Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity,” J Biol Chem 266(18):12029-34 (1991). |
Eisenberg et al (1982). Nature, vol. 229, pp. 371-374. |
Johansson (1974), Acta Chemica Scandinavica, vol. 28, pp. 873-882. |
Walter et al (1994), Methods in Enzymology, vol. 228, pp. 28-42 and 627-640. |
Harris et al (1991), Bioseparation, vol. 2, pp. 237-246. |
Alred et al. (1993), J. Chromatography, vol. 628, pp. 205-214. |
Alred et al (1992), Bioseparation,vol. 2, pp. 363-373. |
Alred et al (1994), J. Chromatography A, vol. 659, pp. 289-298. |
Bradford (1976), Analytical Biochemistry, vol. 72, pp. 248-254. |
Berggren et al (1995), J. Chromatography A vol. 718, pp. 67-79. |
Frandeschini et al (1980), J. Clin. Invewst, vol. 66, pp. 892-900. |
Weisgraber et al (1983), J. Bio. Chem., vol. 258, No. 4, pp. 2508-2513. |
Gualandri et al (1985), Am. J. Hum. Genet., vol. 37, pp. 1083-1097. |
Nguyen et al (1988), Appl. Microbiol Biotechnology, vol. 27, pp. 341-346. |
Modlin et al (1974), J. of Chromatography A, vol. 668, pp. 229-236. |
Galaev et al (1993), Enzyme Microb. Technol, vol. 15, pp. 354-366. |
Deeb et al (1991), J. Biological Chemistry, vol. 266, No. 21, pp. 13654-13660. |
Takada et al, (1991), J. Lipid Research, vol. 32, pp. 1275-1280. |
Matsunaga et al (1991), Proc. Natl. Acad. Sci. USA, vol. 88, pp. 2793-2797. |
Sirtori et al (1993), Human Apolipoprotein Mutants III, NATO ASI Series, vol. II 73, pp. 81-96. |
Brewer et al (1978), Biochemical and Biophysical Research Communications, vol. 80, No. 3, pp. 623-630. |
Weisbrager (1980), J. Clin. Invest., vol. 66, pp. 901-907. |
Wiegel et al (1994), J. Chromatography β, vol. 661, pp. 159-164. |